$709 Million is the total value of Meditor Group Ltd's 36 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
JCPNQ | New | J.C. PENNEY CO INC | $39,623,000 | – | 4,500,000 | +100.0% | 5.59% | – |
BKS | Buy | BARNES & NOBLE INC | $36,879,000 | +164.1% | 2,850,000 | +225.7% | 5.20% | +175.0% |
LIFE | Buy | LIFE TECHNOLOGIES CORP | $31,952,000 | +99.0% | 427,000 | +96.8% | 4.51% | +107.2% |
6107SC | Buy | URS CORP | $20,281,000 | +19.3% | 377,324 | +4.8% | 2.86% | +24.2% |
DDS | New | DILLARDS INC-CL Acl a | $19,184,000 | – | 245,000 | +100.0% | 2.70% | – |
SPY | New | SPDR S&P 500 ETF TRUSTetf | $18,096,000 | – | 107,708 | +100.0% | 2.55% | – |
UHS | Buy | UNIVERSAL HEALTH SERVICES-Bcl b | $15,748,000 | +135.2% | 210,000 | +110.0% | 2.22% | +144.9% |
OREX | Buy | OREXIGEN THERAPEUTICS INC | $12,873,000 | +15.9% | 2,100,000 | +10.5% | 1.82% | +20.7% |
NBIX | Buy | NEUROCRINE BIOSCIENCES INC | $11,886,000 | +229.0% | 1,050,000 | +288.9% | 1.68% | +242.7% |
PACD | Buy | PACIFIC DRILLING SA | $4,045,000 | +50.4% | 365,100 | +32.8% | 0.57% | +56.6% |
BMRN | New | BIOMARIN PHARMACEUTICAL INC | $3,977,000 | – | 55,100 | +100.0% | 0.56% | – |
GTE | New | GRAN TIERRA ENERGY INC | $461,000 | – | 63,000 | +100.0% | 0.06% | – |
INFN | New | INFINERA CORP | $276,000 | – | 24,400 | +100.0% | 0.04% | – |
HTZ | New | HERTZ GLOBAL HOLDINGS INC | $266,000 | – | 12,000 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-10-25
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
EXELIXIS INC | 43 | Q4 2023 | 88.9% |
ALKERMES PLC | 31 | Q4 2020 | 62.6% |
ISHARES MSCI INDIA ETF | 31 | Q4 2023 | 5.5% |
WISDOMTREE INDIA EARNINGS FUND | 31 | Q4 2023 | 5.5% |
ESPERION THERAPEUTICS INC | 27 | Q4 2023 | 34.4% |
VIVUS INC | 15 | Q4 2016 | 21.3% |
CELLDEX THERAPEUTICS | 14 | Q2 2020 | 2.7% |
PROSHARES ULTRAPRO SHORT S&P500 | 4 | Q4 2017 | 3.8% |
PROSHARES ULTRASHORT S&P500 | 4 | Q4 2017 | 3.0% |
PROSHARES ULTRASHORT S&P 500 ETF | 3 | Q3 2019 | 0.8% |
View Meditor Group Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
EXELIXIS, INC. | April 09, 2019 | 15,001,073 | 5.0% |
VIVUS INC | December 19, 2012 | 5,002,896 | 5.0% |
VIVUS INC | March 21, 2012 | 6,177,500 | 6.3% |
VION PHARMACEUTICALS INC | February 15, 2008 | 5,736,200 | 7.6% |
CYPRESS BIOSCIENCE INC | September 26, 2007 | 1,864,645 | 5.0% |
ONYX PHARMACEUTICALS INC | September 12, 2007 | 2,627,800 | 4.8% |
ACUSPHERE INC | July 26, 2007 | 1,839,421 | 4.0% |
NOVACEA INC | June 11, 2007 | 800,000 | 3.4% |
ATHEROGENICS INC | May 02, 2007 | 1,361,800 | 3.5% |
View Meditor Group Ltd's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-11 |
13F-HR | 2024-01-04 |
SC 13G/A | 2024-01-03 |
13F-HR | 2023-10-31 |
13F-HR | 2023-07-25 |
13F-HR | 2023-04-10 |
13F-HR | 2023-01-05 |
SC 13G/A | 2023-01-04 |
13F-HR | 2022-11-07 |
13F-HR | 2022-07-18 |
View Meditor Group Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.